Medical use

MA39828AUndetermined Publication Date: 2015-12-03ALMIRALL SA

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA39828
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-10-17
Filing Date: 2015-05-21
Publication Date: 2015-12-03

Application Information

Patent Timeline

17 Oct 2014

Priority

21 May 2015

Application

MA39828

03 Dec 2015

Publication

MA39828A

IPC: A61K31/53; A61K31/573; A61K45/06; A61P17/00

CPC: A61K31/53; A61K45/06; C07D487/04; A61K31/573; A61K2300/00; A61P1/04; A61P11/00; A61P11/02

Inventors: BALAGUE PELAEZ Cristina; GODESSART MARINA Nuria

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention provides a compound, which is an inhibitor of phosphoinositide 3-kinase delta or a pharmaceutically acceptable salt and / or solvate thereof, for use in the treatment of an immunobullous skin disease mediated by autoantibodies by oral administration.

Need to check novelty before this filing date? Find Prior Art